Lack of Foxp3+ macrophages in both untreated and B16 melanoma-bearing mice.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2012-02-02
Metadata
Show full item recordThe following license files are associated with this item:
Related articles
- Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth.
- Authors: Manrique SZ, Correa MA, Hoelzinger DB, Dominguez AL, Mirza N, Lin HH, Stein-Streilein J, Gordon S, Lustgarten J
- Issue date: 2011 Jul 4
- Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.
- Authors: Hansen W, Hutzler M, Abel S, Alter C, Stockmann C, Kliche S, Albert J, Sparwasser T, Sakaguchi S, Westendorf AM, Schadendorf D, Buer J, Helfrich I
- Issue date: 2012 Oct 22
- T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3.
- Authors: Quatromoni JG, Morris LF, Donahue TR, Wang Y, McBride W, Chatila T, Economou JS
- Issue date: 2011 Nov 23
- Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas.
- Authors: Furudate S, Fujimura T, Kambayashi Y, Kakizaki A, Hidaka T, Aiba S
- Issue date: 2017 Jul
- Adenosine A(2B) receptor antagonist PSB603 suppresses tumor growth and metastasis by inhibiting induction of regulatory T cells.
- Authors: Kaji W, Tanaka S, Tsukimoto M, Kojima S
- Issue date: 2014 Apr